Predicting Short-Term Mortality in Elderly ICU Patients with Diabetes and Heart Failure: A Distributional Inference Framework

📅 2025-06-18
📈 Citations: 0
Influential: 0
📄 PDF

career value

204K/year
🤖 AI Summary
Existing short-term mortality prediction models for elderly ICU patients aged 65–90 years with comorbid diabetes and heart failure lack personalization and uncertainty quantification. Method: We propose the Distributed Risk Estimation and Assessment Modeling (DREAM) framework—a novel distributional inference approach tailored to this high-risk subgroup, yielding posterior risk distributions rather than point estimates. DREAM integrates two-stage feature selection, CatBoost-based modeling, Accumulated Local Effects (ALE) interpretability analysis, and ablation studies to ensure clinical transparency and robustness. Results: Evaluated on MIMIC-IV (n = 1,478), DREAM achieves an AUROC of 0.863 and identifies 19 clinically relevant predictors, with APS III score, oxygen flow rate, GCS eye response, and Braden activity subscore emerging as the strongest mortality indicators. This work enables individualized, probabilistic, and interpretable short-term mortality risk assessment for critically ill older adults.

Technology Category

Application Category

📝 Abstract
Elderly ICU patients with coexisting diabetes mellitus and heart failure experience markedly elevated short-term mortality, yet few predictive models are tailored to this high-risk group. Diabetes mellitus affects nearly 30% of U.S. adults over 65, and significantly increases the risk of heart failure. When combined, these conditions worsen frailty, renal dysfunction, and hospitalization risk, leading to one-year mortality rates of up to 40%. Despite their clinical burden and complexity, no established models address individualized mortality prediction in elderly ICU patients with both diabetes mellitus and heart failure. We developed and validated a probabilistic mortality prediction framework using the MIMIC-IV database, targeting 65-90-year-old patients with both diabetes mellitus and heart failure. Using a two-stage feature selection pipeline and a cohort of 1,478 patients, we identified 19 clinically significant variables that reflect physiology, comorbidities, and intensity of treatment. Among six ML models benchmarked, CatBoost achieved the highest test AUROC (0.863), balancing performance and interpretability. To enhance clinical relevance, we employed the DREAM algorithm to generate posterior mortality risk distributions rather than point estimates, enabling assessment of both risk magnitude and uncertainty. This distribution-aware approach facilitates individualized triage in complex ICU settings. Interpretability was further supported via ablation and ALE analysis, highlighting key predictors such as APS III, oxygen flow, GCS eye, and Braden Mobility. Our model enables transparent, personalized, and uncertainty-informed decision support for high-risk ICU populations.
Problem

Research questions and friction points this paper is trying to address.

Predict short-term mortality in elderly ICU patients with diabetes and heart failure
Develop a probabilistic mortality prediction framework using clinical variables
Enhance clinical relevance with distributional risk assessment and interpretability
Innovation

Methods, ideas, or system contributions that make the work stand out.

Probabilistic mortality prediction using MIMIC-IV database
Two-stage feature selection for 19 clinical variables
DREAM algorithm for posterior risk distributions
🔎 Similar Papers
No similar papers found.
💼 Related Jobs
Postdoctoral Fellow – AI-Driven Multi-Omics Integration for Predictive Toxicology
Pfizer
The annual base salary for this position ranges from $64,600.00 to $107,600.00. In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 7.5% of the base salary. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States. Relocation assistance may be available based on business needs and/or eligibility.
Hybrid
Junyi Fan
Junyi Fan
University of Southern California
machine learning
Shuheng Chen
Shuheng Chen
University of Southern California
Machine LearningData SciencePredictive AnalyticsClinical Prediction
L
Li Sun
Department of Industrial and Systems Engineering, University of Southern California, Los Angeles, CA, United States.
Y
Y. Si
Department of Industrial and Systems Engineering, University of Southern California, Los Angeles, CA, United States.
E
E. Pishgar
Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran.
K
K. Alaei
Department of Health Science, California State University, Long Beach, CA, United States.
G
G. Placencia
Department of Industrial and Manufacturing Engineering, California State Polytechnic University, Pomona, CA, United States.
M
M. Pishgar
Department of Industrial and Systems Engineering, University of Southern California, Los Angeles, CA, United States.